000			01658 a2200457 4500
005			20250514160559.0
264		0	_c20031103
008			200311s 0 0 eng d
022			_a1097-6744
024	7		_a10.1016/S0002-8703(03)00317-X _2doi
040			_aNLM _beng _cNLM
100	1		_aGurbel, Paul A
245	0	0	_aPlatelet activation after stenting with heparin-coated versus noncoated stents. _h[electronic resource]
260			_bAmerican heart journal _cOct 2003
300			_aE10 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAnticoagulants _xadministration & dosage
650	0	4	_aAspirin _xadministration & dosage
650	0	4	_aBiomarkers _xblood
650	0	4	_aBlood Platelets _xdrug effects
650	0	4	_aDual Specificity Phosphatase 2
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aHeparin _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aP-Selectin _xblood
650	0	4	_aPilot Projects
650	0	4	_aPlatelet Activation
650	0	4	_aPlatelet Aggregation _xdrug effects
650	0	4	_aPlatelet Glycoprotein GPIIb-IIIa Complex _xmetabolism
650	0	4	_aPlatelet Membrane Glycoprotein IIb _xblood
650	0	4	_aProspective Studies
650	0	4	_aProtein Phosphatase 2
650	0	4	_aProtein Tyrosine Phosphatases _xblood
650	0	4	_aStents
700	1		_aBliden, Kevin P
773	0		_tAmerican heart journal _gvol. 146 _gno. 4 _gp. E10
856	4	0	_uhttps://doi.org/10.1016/S0002-8703(03)00317-X _zAvailable from publisher's website
999			_c14307131 _d14307131